Abstract
The aim of the present study was to investigate whether the early changes in the immune system observed after ABMT would persist over years. Eighty-five patients with malignant lymphoma were treated with ABMT in Norway from 1987 until 1993. Of the 46 patients in CR by 1997, 36 were enrolled in our study. Median time from ABMT was 5 years (4–10 years). Immunophenotyping showed an increase in the median number of B cells (0.35 × 109/l in patients vs 0.28 × 109/l in controls), and a decrease in T cells (1.08 vs 1.35 × 109/l). Furthermore, a lower median count of CD4+ T cells (0.54 × 109/l in patients vs0.87 × 109/l in controls) resulted in reduced CD4/CD8 ratios (0.8 in patients vs 1.6 in controls). The subgroup of CD4+ T cells expressing the ‘naive’ phenotype CD45RA was 19.5% in patients vs 38% in controls. In contrast, the fraction expressing the ‘memory’ phenotype CD45RO was higher in the ABMT group (76% vs 54%). When stimulated, larger fractions of CD3+CD4+ cells in patients produced IFN-γ (32% vs 16%) or IL-4 (7% vs 1%) compared to controls; thus a differentiation into the functionally separate subgroups Th1 and Th2, with a dominant Th2 response. Our data further suggest that the decrease in CD4+ T cell counts and the imbalance between CD45RA+ and CD45RO+ subsets persists 4–10 years after ABMT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nordøy, T., Kolstad, A., Endresen, P. et al. Persistent changes in the immune system 4–10 years after ABMT. Bone Marrow Transplant 24, 873–878 (1999). https://doi.org/10.1038/sj.bmt.1702006
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702006
Keywords
This article is cited by
-
Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma
Bone Marrow Transplantation (2012)
-
ARDS Caused by Herpes Simplex Virus Late After Stem Cell Transplant
Infection (2007)
-
Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study
Bone Marrow Transplantation (2005)
-
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation
Bone Marrow Transplantation (2003)
-
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors
Bone Marrow Transplantation (2003)